Skip to main content
SpringerLink
Log in

Very late recurrence (after more than 20 years) of epithelial ovarian carcinoma: case report and literature review

  • Review
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To present a case of very late (more than 20 years) recurrence of epithelial ovarian carcinoma and to review the pertinent literature. We encountered a 50-year-old patient who, at the age of 22, underwent cytoreductive surgery and adjuvant chemotherapy for stage III serous ovarian carcinoma. She recurred after 28 years and underwent secondary surgery and chemotherapy.

Method

A PubMed search of the English literature containing the following key words: ovarian cancer, late recurrence, late relapse, late metastasis was performed.

Results

Only five cases (including the present one) with recurrence after more than 20 years are so far on record. Of these, four patients were 33 years old or younger and had advanced stage at diagnosis. Time to recurrence ranged from 21 to 28 years. All patients had serous carcinoma and three had recurrence in lymph nodes.

Conclusions

Very late recurrence is an extremely rare event and may result from either regrowth of dormant tumor cells or from development of a new cancer. Lifelong follow-up is critically important for ovarian cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. 55:74

  2. Ozols RF (2006) Systemic therapy for ovarian cancer: current status and new treatments. Semin Oncol 33(2 Suppl 6):S3–S11

    Article  CAS  PubMed  Google Scholar 

  3. Dowdy SC, Pfeifer EA, Longcope DC, Cliby WA (1999) Unusual recurrence of ovarian carcinoma 9 years after initial diagnosis. Gynecol Oncol 74:495–498

    Article  CAS  PubMed  Google Scholar 

  4. Bamias A, Efstathiou E, Vassilakopoulou M, Koutsoukou V, Papadimitriu C, Rodolakis A et al (2005) Late relapse of epithelial ovarian cancer: a single institution experience. Eur J Gynaecol Oncol 26:439–442

    CAS  PubMed  Google Scholar 

  5. Sahdev A, Hughes JH, Barwick T, Rockall AG, Gallagher CJ, Reznek RH (2007) Computed tomography features of recurrent ovarian carcinoma according to time to relapse. Acta Radiol 48:1038–1044

    Article  CAS  PubMed  Google Scholar 

  6. Testelmans D, Van Raemdonck D, Amant F, De Wever W, Verbeken E, Nackaerts K (2010) Late recurrent ovarian carcinoma metastatic to the thoracic wall. Acta Clin Belg 65:354–356

    Article  CAS  PubMed  Google Scholar 

  7. Zylberberg B, Dormont D, Madelenat P, Daraï E (2004) Relapse after more than 20 years of follow-up for epithelial ovarian carcinoma. Obstet Gynecol 103:1082–1084

    Article  PubMed  Google Scholar 

  8. Buller RE, Skilling JS, Sood AK, Plaxe S, Baergen RN, Lager DJ (1998) Field cancerization: why late “recurrent” ovarian cancer is not recurrent. Am J Obstet Gynecol 178:641–649

    Article  CAS  PubMed  Google Scholar 

  9. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BAJ et al (1992) Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 84:1793–1798

    Article  CAS  PubMed  Google Scholar 

  10. Ruppender NS, Morrissey C, Lange PH, Vessella RL (2013) Dormency in solid Tumors implication for prostate cancer. Cancer Metastasis Rev 32:501–509

    Article  PubMed  Google Scholar 

  11. Hedley BD, Chambers AF (2009) Tumor dormancy and metastasis. Adv Cancer Res 102:67–101

    Article  CAS  PubMed  Google Scholar 

  12. Winquist RJ, Boucher DM, Wood M, Furey BF (2009) Targeting cancer stem cells for more effective therapies: taking out cancer’s locomotive engine. Biochem Pharmacol 78:326–334

    Article  CAS  PubMed  Google Scholar 

  13. Tomao F, Papa A, Strudel M, Rossi L, Lo Russo G, Benedetti Panici P et al (2014) Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. J Cancer 5:301–310

    Article  PubMed Central  PubMed  Google Scholar 

  14. Murphy SK (2010) Targeting ovarian cancer-initiating cells. Anticancer Agents Med Chem 10:157–163

    Article  CAS  PubMed  Google Scholar 

  15. Zhou B-BS, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB (2009) Tumour initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8:806–823

    Article  CAS  PubMed  Google Scholar 

  16. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al (2008) Identification and characterization of ovarian cancer Initiating cells from primary human tumors. Cancer Res 68:4311–4320

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Vang R, Shih IeM, Kurman RJ (2009) Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16:267–282

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, E. Wolfson Medical Center, Holon, Israel

    Joseph Menczer, Ofri Peled & Tally Levy

  2. Department of Pathology, E. Wolfson Medical Center, Holon, Israel

    Letizia Schreiber

  3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Letizia Schreiber

Authors
  1. Joseph Menczer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Letizia Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ofri Peled
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tally Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph Menczer.

Additional information

Both first authors contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Menczer, J., Schreiber, L., Peled, O. et al. Very late recurrence (after more than 20 years) of epithelial ovarian carcinoma: case report and literature review. Arch Gynecol Obstet 291, 1199–1203 (2015). https://doi.org/10.1007/s00404-014-3597-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-014-3597-6

Keywords

Search

Navigation